Jan Portegys Anke Heidemeier Andreas Rosenwald Michael Gernert Matthias Fröhlich Sebastian Hueper Patrick Pascal Strunz Leo Rasche Marc Schmalzing
10.1136/rmdopen-2022-002852
RMD Open
2023 Jan;9(1):e002852.
arthritis autoimmune diseases biological therapy glucocorticoids magnetic resonance imaging
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36693681/
Arthritis Erdheim-Chester Disease / diagnosis Erdheim-Chester Disease / drug therapy Erdheim-Chester Disease / genetics Histiocytosis, Sinus / diagnosis Histiocytosis, Sinus / drug therapy Histiocytosis, Sinus / genetics
Arthritis Erdheim-Chester Disease / diagnosis Erdheim-Chester Disease / drug therapy Erdheim-Chester Disease / genetics Histiocytosis, Sinus / diagnosis Histiocytosis, Sinus / drug therapy Histiocytosis, Sinus / genetics Case Reports Humans Interleukin 1 Receptor Antagonist Protein / therapeutic use Methotrexate / therapeutic use upadacitinib Interleukin 1 Receptor Antagonist Protein Methotrexate
PMC9884847
36693681
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib
2023